![](/img/cover-not-exists.png)
PD-006Final analysis of stage 1 data from a randomized phase 2 study of PEGPH20 plus nab-paclitaxel/gemcitabine in stage IV previously untreated pancreatic cancer patients, utilizing Ventana companion diagnostic assay
Hingorani, S., Bullock, A., Harris, W., Wu, W., Jiang, P., Chondros, D., Khelifa, S., Aldrich, C., Pu, J., Hendifar, A.Volume:
27
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw200.06
Date:
June, 2016
File:
PDF, 139 KB
2016